Feature Stories

Kate Giovino named to the 2018 PharmaVOICE 100

Aug 1, 2018

Astellas Americas’ Senior Director, Clinical Operations, AIRM, Kate Giovino was recently named a 2018 PharmaVOICE 100 honoree in the August edition of PharmaVOICE magazine in recognition of her contributions to the life-sciences industry.

“I am honored and humbled to be included with such an accomplished group of life sciences professionals,” said Giovino. “Such recognition would not be possible without the support of my team, with whom I remain committed to making a difference in the lives of people worldwide.”

The PharmaVOICE 100 honorees represent a broad cross section of the global life-sciences industry, including pharmaceutical, biopharmaceutical, biotechnology, contract research, clinical trial, research and development, patient education, advertising, digital, marketing, technology, academia, and many other sectors. This diverse group of individuals also represents a wide variety of functional areas ranging from the clinic to the C-suite.

Honorees are nominated by thousands of PharmaVOICE readers throughout the year and are selected based on substantive accounts describing how they have inspired or motivated their colleagues, peers, and even competitors; have affected positive changes in their own organizations through innovative and game-changing strategies and thinking; as well as giving back to their communities and other philanthropic causes.

To read Kate Giovino’s full profile, click here.